about
Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study.Molecular spectrum of TSHβ subunit gene defects in central hypothyroidism in the UK and IrelandAssessment of childhood obesity in secondary care: OSCA consensus statement.Is the incidence of type 1 diabetes in children and adolescents stabilising? The first 6 years of a National Register.Adiposity in Children Born Small for Gestational Age Is Associated With β-Cell Function, Genetic Variants for Insulin Resistance, and Response to Growth Hormone Treatment.Body fat distribution in Turner syndrome and the influence of puberty.Coeliac disease in Turner syndrome.Treatment outcome in Turner syndrome.Baseline IGF-I levels determine insulin secretion and insulin sensitivity during the first year on growth hormone therapy in children born small for gestational age. Results from a North European Multicentre Study (NESGAS).Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes.Height in Turner syndrome: does growth hormone therapy have impact?Turner syndrome: awareness of health issues.Health-related quality of life in Turner syndrome and the influence of key features.Thyroid disorders in girls with Turner syndrome and the influence of the underlying karyotype.Social networking patterns/hazards among teenagers.The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS).Bone mineral density in Turner's syndrome and the influence of pubertal development.Genetic Markers of Insulin Sensitivity and Insulin Secretion Are Associated With Spontaneous Postnatal Growth and Response to Growth Hormone Treatment in Short SGA Children: the North European SGA Study (NESGAS)A randomised controlled trial evaluating IGF1 titration in contrast to current GH dosing strategies in children born small for gestational age: the North European Small-for-Gestational-Age StudyPersonalized Cardio-Metabolic Responses to an Anti-Inflammatory Nutrition Intervention in Obese Adolescents: A Randomized Controlled Crossover TrialSingle Centre Experience - Clinical Presentation and Frequency of Paediatric Diabetic Ketoacidosis (DKA) At Diagnosis over a 5-Year PeriodAltered endotoxin responsiveness in healthy children with Down syndromeTrends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration studyChildhood obesity--why should we be worried?Differences between males and females in the seasonality of birth and month of clinical onset of disease in children with type 1 diabetes mellitus in IrelandNational incidence of type 1 diabetes in childhood and adolescenceIncidence of type 1 diabetes mellitis in children aged under 15 years in the Republic of IrelandThyroid dysfunction in Down's syndrome and screening for hypothyroidism in children and adolescents using capillary TSH measurementMaturity Onset Diabetes in the Young (MODY) type 3Clinical presentation of type 1 diabetesIrish Childhood National Diabetes RegisterChildhood protection and obesity: framework for practiceThe National Paediatric Diabetes Register and its impact on healthcareMode of initial presentation and chromosomal abnormalities in Irish patients with Turner syndrome: a single-centre experienceThe incidence of childhood type 1 diabetes in Ireland and the National Childhood Diabetes RegisterBone Mineral Density in Short Individuals; How Can We Interpret It?A novel IGSF1 mutation in a large Irish kindred highlights the need for familial screening in the IGSF1 deficiency syndromeFifteen-minute consultation: Polydipsia, polyuria or bothEED and EZH2 constitutive variants: A study to expand the Cohen-Gibson syndrome phenotype and contrast it with Weaver syndromeAre girls with Turner syndrome obese?
P50
Q37189175-FEAE3FF1-D78E-43A8-89B9-1488F537BC7AQ37663895-2BBAA5EC-5AE6-4FEE-93B8-49D945257F8BQ38011676-D07C6387-114F-4289-A005-BDAB7EC333C2Q39360307-0E186FDD-6D27-4700-87DB-92C6766ECB4FQ40297029-A7EB319A-A85B-4A98-B6F6-4A88D80368ABQ44131929-5AD4B4D7-8B3F-43A2-AF7D-7EE929CC4504Q44214413-C9AF04B8-09E8-4396-B23B-FFC6D823E9BCQ44823508-35C4A68A-930B-4296-9686-7FA1CFFDB128Q46295452-EB0AC4F4-BC96-4757-9FCA-4308C4B85AD1Q46608375-D096A2F1-3FEC-4B68-822F-647B5F985EF2Q47177803-963E8536-62C2-4AE1-A448-79640CB7D1D0Q48065326-0812466A-0D47-45EC-8EC5-1FB084559C53Q48152090-439C258F-5A97-4368-AFA2-FC5F958061E6Q50931110-AB8F6899-4E41-4825-A237-41300A27AE02Q51470463-D6DE5B85-8539-47F7-893D-F36538BDA23AQ52683077-772FB23D-77F6-479F-A370-5E296D5B5893Q54417723-AD5D6E87-9187-4CEB-9122-ADC68717E50CQ57315762-79C08A67-7BE5-44F4-AAC2-48B8D0DAB6B5Q57420583-CCA20FDB-3546-405D-9FBF-8A92CFE86025Q57699996-0244A9BB-86AC-444A-9A56-5562AA84CA7EQ58131696-88930599-59F9-4B1E-BC77-BE7153DF4E7DQ58613664-7E6FA8A3-F222-437C-8CB8-21884E117069Q61306971-A7F603B5-FCA3-43FF-8903-38CA231AF519Q73494818-D074DAD3-AB62-4F3C-AAB0-7AA07EB3A871Q73706299-8EEB7BF4-743B-4A36-9419-A230DC448BA2Q74385727-ED32968E-5042-48ED-B76A-B12516985AD2Q78394802-9B6D19E1-735E-4BDF-ABB6-E4164AA33A54Q81111584-36508564-57B6-4652-B723-CFA6E82EFB0CQ81555639-96467EC5-F3B8-46ED-8593-FEE10EB89C9AQ81863872-A05DD9B1-7B4C-44C6-9233-FD0A8FE2A433Q82759700-BCD3F7DB-82DC-4783-9BA4-991B932C9200Q84572192-2471EEAB-0DB0-4AA6-B897-C9481FCEE7B8Q85321232-FC656339-B2F6-4FF5-91BE-06262EC9292BQ85932837-AD3244A1-DE08-4DC3-89A2-1852B0656DDFQ86040090-B50DF3BB-FFC1-45EE-B4FF-AB8CF18A84C7Q89915395-627E7D8A-134C-437A-BD47-1CD7156D17CBQ90817012-43FD4E44-26A8-4346-95E2-D5C7BEE443A8Q91068199-D4F11F1E-FE8E-4E6F-A0EC-01C2DDB8569FQ91823331-F7140419-C2DA-4506-8BC5-852802846BADQ95396786-B83C4733-1A2C-4672-8F6F-8BC651E9AEA2
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-7266-8649
@en
name
Edna Roche
@ast
Edna Roche
@en
Edna Roche
@es
Edna Roche
@nl
type
label
Edna Roche
@ast
Edna Roche
@en
Edna Roche
@es
Edna Roche
@nl
altLabel
edna roche
@en
prefLabel
Edna Roche
@ast
Edna Roche
@en
Edna Roche
@es
Edna Roche
@nl
P106
P1153
7005472893
P2798
P31
P496
0000-0001-7266-8649